Literature DB >> 23596312

Bruton's tyrosine kinase is required for apoptotic cell uptake via regulating the phosphorylation and localization of calreticulin.

Jennifer C Byrne1, Joan Ní Gabhann, Kevin B Stacey, Barbara M Coffey, Eoghan McCarthy, Warren Thomas, Caroline A Jefferies.   

Abstract

In addition to regulating B cell development and activation, Bruton's tyrosine kinase (Btk) functions downstream of multiple TLRs, including TLR7, to regulate innate immune responses in myeloid cells. Although critical for defense against RNA viruses such as influenza and Sendai virus, recognition of self-RNA by TLR7 also has been shown to be an important contributor to the pathophysiology of systemic lupus erythematosus. To date, the role of Btk in regulating TLR7-mediated responses is poorly understood. In the current study, we have demonstrated a hitherto undiscovered role for Btk in apoptotic cell uptake, identifying the molecular chaperone calreticulin (CRT) as a novel substrate for Btk in regulating this response. CRT together with the transmembrane receptor CD91 function at the cell membrane and regulate uptake of C1q-opsonised apoptotic cells. Our results show that Btk directly phosphorylates CRT and that in the absence of Btk, CRT fails to localize with CD91 at the cell surface and at the phagocytic cup. Critically, a blocking Ab against CRT in wild-type macrophages mimics the inability of Btk-deficient macrophages to phagocytose apoptotic cells efficiently, indicating the critical importance of Btk in regulating CRT-driven apoptotic cell uptake. Our data have revealed a novel regulatory role for Btk in mediating apoptotic cell clearance, with CRT identified as the critical component of the CRT/CD91/C1q system targeted by Btk. Given the importance of clearing apoptotic cell debris to prevent inappropriate exposure of TLRs to endogenous ligands, our results have important implications regarding the role of Btk in myeloid cell function.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23596312     DOI: 10.4049/jimmunol.1300057

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

Review 1.  The role of tyrosine kinases in systemic lupus erythematosus and their potential as therapeutic targets.

Authors:  Wen-Hai Shao; Philip L Cohen
Journal:  Expert Rev Clin Immunol       Date:  2014-03-29       Impact factor: 4.473

2.  Impact of Calreticulin and Its Mutants on Endoplasmic Reticulum Function in Health and Disease.

Authors:  Najla Arshad; Peter Cresswell
Journal:  Prog Mol Subcell Biol       Date:  2021

3.  Complement protein C1q bound to apoptotic cells suppresses human macrophage and dendritic cell-mediated Th17 and Th1 T cell subset proliferation.

Authors:  Elizabeth V Clarke; Brian M Weist; Craig M Walsh; Andrea J Tenner
Journal:  J Leukoc Biol       Date:  2014-11-07       Impact factor: 4.962

Review 4.  I'm Infected, Eat Me! Innate Immunity Mediated by Live, Infected Cells Signaling To Be Phagocytosed.

Authors:  Tim Birkle; G C Brown
Journal:  Infect Immun       Date:  2021-04-16       Impact factor: 3.441

5.  Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma.

Authors:  Michail S Lionakis; Kieron Dunleavy; Mark Roschewski; Brigitte C Widemann; John A Butman; Roland Schmitz; Yandan Yang; Diane E Cole; Christopher Melani; Christine S Higham; Jigar V Desai; Michele Ceribelli; Lu Chen; Craig J Thomas; Richard F Little; Juan Gea-Banacloche; Sucharita Bhaumik; Maryalice Stetler-Stevenson; Stefania Pittaluga; Elaine S Jaffe; John Heiss; Nicole Lucas; Seth M Steinberg; Louis M Staudt; Wyndham H Wilson
Journal:  Cancer Cell       Date:  2017-05-25       Impact factor: 31.743

6.  Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib.

Authors:  Farrukh T Awan; Anna Schuh; Jennifer R Brown; Richard R Furman; John M Pagel; Peter Hillmen; Deborah M Stephens; Jennifer Woyach; Elena Bibikova; Prista Charuworn; Melanie M Frigault; Ahmed Hamdy; Raquel Izumi; Bolan Linghu; Priti Patel; Min Hui Wang; John C Byrd
Journal:  Blood Adv       Date:  2019-05-14

7.  Macrophages eat cancer cells using their own calreticulin as a guide: roles of TLR and Btk.

Authors:  Mingye Feng; James Y Chen; Rachel Weissman-Tsukamoto; Jens-Peter Volkmer; Po Yi Ho; Kelly M McKenna; Samuel Cheshier; Michael Zhang; Nan Guo; Phung Gip; Siddhartha S Mitra; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

8.  Tumor-associated calreticulin variants functionally compromise the peptide loading complex and impair its recruitment of MHC-I.

Authors:  Najla Arshad; Peter Cresswell
Journal:  J Biol Chem       Date:  2018-05-16       Impact factor: 5.157

Review 9.  Evolution of normal and neoplastic tissue stem cells: progress after Robert Hooke.

Authors:  Irving Weissman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-10-19       Impact factor: 6.237

Review 10.  Phagocytosis checkpoints as new targets for cancer immunotherapy.

Authors:  Mingye Feng; Wen Jiang; Betty Y S Kim; Cheng Cheng Zhang; Yang-Xin Fu; Irving L Weissman
Journal:  Nat Rev Cancer       Date:  2019-08-28       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.